Update on massive transfusion

British Journal of Anaesthesia

Volumn 111, Issue SUPPL.1, 2013, Pages

  Pham, H P ^a,b   Shaz, B H ^a,c  

^a NEW YORK BLOOD CENTER   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

massive transfusion; massive transfusion protocol; paediatric transfusion protocol; transfusion management

Indexed keywords

FIBRINOGEN CONCENTRATE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 9; TRANEXAMIC ACID;

ACIDOSIS; AIR EMBOLISM; ALGORITHM; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD CLOTTING PARAMETERS; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CIRCULATION; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); CRYOPRECIPITATE; DRUG EFFICACY; EARLY TRAUMA INDUCED COAGULOPATHY; EPIDEMIOLOGICAL DATA; ERYTHROCYTE TRANSFUSION; FIBRINOGEN DEFECT; FIBRINOLYSIS; GROUPS BY AGE; HEALTH CARE PERSONNEL; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HUMAN; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOTHERMIA; IMMUNOMODULATION; INFECTION; INJURY; INTERPERSONAL COMMUNICATION; ISCHEMIA; LABORATORY TEST; MASSIVE TRANSFUSION; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; METABOLIC DISORDER; MORTALITY; NONHUMAN; OBSTETRIC HEMORRHAGE; OPERATIVE BLOOD LOSS; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT MONITORING; PLASMA TRANSFUSION; POSTPARTUM HEMORRHAGE; POSTTRANSFUSION PURPURA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PURPURA; RESUSCITATION; RISK BENEFIT ANALYSIS; ROTATIONAL THROMBOELASTOGRAPHY; SCORING SYSTEM; SENSITIZATION; TEAMWORK; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; THROMBOEMBOLISM; THROMBOSIS; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; TRANSFUSION RELATED ACUTE LUNG INJURY; TRANSFUSION RELATED IMMUNOMODULATION; TRAUMA ASSOCIATED SEVERE HEMORRHAGE SCORE; TREATMENT OUTCOME;

EID: 84890608558     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet376     Document Type: Article

References (104)

1. RaymerJM, Flynn LM, Martin RF. Massive transfusion of blood in the surgical patient. Surg Clin North Am 2012; 92: 221-34, vii
2. Levy JH. Massive transfusion coagulopathy. Semin Hematol 2006; 43: S59-63
3. Malone DL, Hess JR, Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma 2006; 60: S91-6
4. Diab YA, Wong EC, Luban NL. Massive transfusion in children and neonates. Br J Haematol 2013; 161: 15-26
5. Seghatchian J, Samama MM. Massive transfusion: an overview of the main characteristics and potential risks associated with substances used for correction of a coagulopathy. Transfus Apher Sci 2012; 47: 235-43
6. Deaths and Mortality. Centers for Disease Control and Prevention, 2010. Available from http://www.cdc.gov/nchs/fastats/deaths .htm (accessed 13 August 2013)
7. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995; 38: 185-93
8. HolcombJB, Jenkins D, Rhee P, et al.Damagecontrol resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007; 62: 307-10
9. Como JJ, Dutton RP, Scalea TM, Edelman BB, Hess JR. Blood transfusion rates in the care of acute trauma. Transfusion 2004; 44: 809-13
10. Friedman AJ. Obstetric hemorrhage. J Cardiothorac Vasc Anesth 2013; 27: S44-8
11. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003; 54: 1127-30
12. Chesebro BB, Rahn P, Carles M, et al. Increase in activated proteinC mediates acute traumatic coagulopathy in mice. Shock 2009; 32: 659-65
13. Gruen RL, Brohi K, Schreiber M, et al. Haemorrhage control in severely injured patients. Lancet 2012; 380: 1099-108
14. Reiss RF. Hemostatic defects in massive transfusion: rapid diagnosis and management. Am J Crit Care 2000; 9: 158-65; quiz 66-7
15. Floccard B, Rugeri L, Faure A, et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 2012; 43: 26-32
16. HendricksonJE, Shaz BH, PereiraG, et al.Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients. J Pediatr 2012; 160: 204-9.e3
17. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predictsmortality in trauma. JTrauma2003; 55: 39-44
18. Patregnani JT, BorgmanMA, Maegele M,WadeCE, Blackbourne LH, Spinella PC. Coagulopathy and shock on admission is associated with mortality for children with traumatic injuries at combat support hospitals. Pediatr Crit Care Med 2012; 13: 273-7
19. Lustenberger T, Talving P, Kobayashi L, et al. Early coagulopathy after isolated severe traumatic brain injury: relationship with hypoperfusion challenged. J Trauma 2010; 69: 1410-4
20. Talving P, Lustenberger T, LamL, et al. Coagulopathy after isolated severe traumatic brain injury in children. J Trauma 2011; 71: 1205-10
21. Sihler KC, Napolitano LM. Complications of massive transfusion. Chest 2010; 137: 209-20
22. Bolliger D, Gorlinger K, Tanaka KA. Pathophysiologyand treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010; 113: 1205-19
23. Sorensen B, Fries D. Emerging treatment strategies for traumainduced coagulopathy. Br J Surg 2012; 99(Suppl. 1): 40-50
24. Ickx BE. Fluid and blood transfusion management in obstetrics. Eur J Anaesthesiol 2010; 27: 1031-5
25. Lier H, KrepH, Schroeder S, Stuber F. Preconditions ofhemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma 2008; 65: 951-60
26. Watts DD, Trask A, Soeken K, Perdue P, Dols S, Kaufmann C. Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 1998; 44: 846-54
27. Martini WZ, Holcomb JB. Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs. Ann Surg 2007; 246: 831-5
28. Stanworth SJ, Morris TP, Gaarder C, et al. Reappraising the concept of massive transfusion in trauma. Crit Care 2010; 14: R239
29. Cotton BA, Au BK, Nunez TC, Gunter OL, Robertson AM, Young PP. Predefinedmassive transfusion protocols are associated withareduction in organ failure and postinjury complications. J Trauma 2009; 66: 41-8; discussion 8-9
30. Cancio LC,Wade CE,West SA, Holcomb JB. Prediction of mortality and of the need for massive transfusion in casualties arriving at combat support hospitals in Iraq. J Trauma 2008; 64: S51-5; discussion S5-6
31. McLaughlin DF, Niles SE, Salinas J, et al. A predictive model for massive transfusion in combat casualty patients. J Trauma 2008; 64: S57-63; discussion S63
32. Schreiber MA, Perkins J, Kiraly L, Underwood S, Wade C, Holcomb JB. Early predictors of massive transfusion in combat casualties. J Am Coll Surg 2007; 205: 541-5
33. Maegele M, Lefering R,Wafaisade A, et al. Revalidation and update of the TASH-score: a scoring system to predict the probability for massive transfusion as a surrogate for life-threatening haemorrhage after severe injury. Vox Sang 2011; 100: 231-8
34. Yucel N, Lefering R, Maegele M, et al. Trauma Associated Severe Hemorrhage (TASH)-score: probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma. J Trauma 2006; 60: 1228-36; discussion 36-7
35. Nunez TC, Voskresensky IV, Dossett LA, Shinall R, Dutton WD, Cotton BA. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)? J Trauma 2009; 66: 346-52
36. Curry N, Davis PW. What's new in resuscitation strategies for the patient with multiple trauma? Injury 2012; 43: 1021-8
37. Armand R, Hess JR. Treating coagulopathy in trauma patients. Transfus Med Rev 2003; 17: 223-31
38. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63: 805-13
39. Johansson PI, Stensballe J. Hemostatic resuscitation for massive bleeding: the paradigm of plasma and platelets-a review of the current literature. Transfusion 2010; 50: 701-10
40. Dzik WH, Blajchman MA, Fergusson D, et al. Clinical review: Canadian National Advisory Committee on Blood and Blood Products- massive transfusion consensus conference 2011: report of the panel. Crit Care 2011; 15: 242
41. Holcomb JB, del Junco DJ, Fox EE, et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 2013; 148: 127-36
42. Shaz BH, Dente CJ, Harris RS, MacLeod JB, Hillyer CD. Transfusion management of trauma patients. Anesth Analg 2009; 108: 1760-8
43. Cotton BA,GuyJS, MorrisJAJr,AbumradNN.Thecellular,metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock 2006; 26: 115-21
44. Cushing M, Shaz BH. Blood transfusion in trauma patients: unresolved questions. Minerva Anestesiol 2011; 77: 349-59
45. Dente CJ, Shaz BH, Nicholas JM, et al. Improvements in early mortalityandcoagulopathyare sustained better in patients with blunt traumaafter institution of amassive transfusion protocol in acivilian level I trauma center. J Trauma 2009; 66: 1616-24
46. Nunez TC, Young PP, Holcomb JB, Cotton BA. Creation, implementation, and maturation of a massive transfusion protocol for the exsanguinating trauma patient. J Trauma 2010; 68: 1498-505
47. O'Keeffe T, Refaai M, Tchorz K, Forestner JE, Sarode R. A massive transfusion protocol to decrease blood component use and costs. Arch Surg 2008; 143: 686-90; discussion 90-1
48. Riskin DJ, Tsai TC, Riskin L, et al. Massive transfusion protocols: the role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 2009; 209: 198-205
49. Gerlach R, Tolle F, Raabe A, Zimmermann M, Siegemund A, Seifert V. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 2002; 33: 1618-23
50. Blome M, Isgro F, Kiessling AH, et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005; 93: 1101-7
51. Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrinogen to redcells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008; 64: S79-85; discussion S85
52. Spinella PC, Perkins JG, Grathwohl KW, et al. Fresh whole blood transfusions in coalition military, foreign national, and enemy combatant patients during Operation Iraqi Freedom at a U.S. combat support hospital.World J Surg 2008; 32: 2-6
53. Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Holcomb JB. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009; 66: S69-76
54. ChandlerMH,Roberts M, Sawyer M,Myers G.TheUSmilitaryexperience with fresh whole blood during the conflicts in Iraq and Afghanistan. Semin Cardiothorac Vasc Anesth 2012; 16: 153-9
55. Gilstad C, Roschewski M,Wells J, et al. Fatal transfusion-associated graft-versus-host disease with concomitantimmunehemolysis in a group A combat trauma patient resuscitated with group O fresh whole blood. Transfusion 2012; 52: 930-5
56. Laverdiere C, Gauvin F, Hebert PC, et al. Survey on transfusion practices of pediatric intensivists.Pediatr CritCareMed2002;3:335-40
57. Ringer SA, Richardson DK, Sacher RA, Keszler M, Churchill WH. Variations in transfusion practice in neonatal intensive care. Pediatrics 1998; 101: 194-200
58. Hendrickson JE, Shaz BH, Pereira G, et al. Implementation of a pediatric trauma massive transfusion protocol: one institution's experience. Transfusion 2012; 52: 1228-36
59. Chidester SJ, Williams N, Wang W, Groner JI. A pediatric massive transfusion protocol. J Trauma Acute Care Surg 2012; 73: 1273-7
60. Zielinski MD, Johnson PM, Jenkins D, Goussous N, Stubbs JR. Emergency use of prethawed group A plasma in trauma patients. J Trauma Acute Care Surg 2013; 74: 69-74; discussion 74-5
61. Yazer MH, Triulzi DJ. Detection of anti-D in D-recipients transfused with D+ red blood cells. Transfusion 2007; 47: 2197-201
62. Cid J, Carbasse G, Pereira A, et al. Platelet transfusions from D+ donors toD2patients:a 10-year follow-up studyof 1014patients. Transfusion 2011; 51: 1163-9
63. Molnar R, Johnson R, Sweat LT, Geiger TL.Absence ofD alloimmunization in D-pediatric oncology patients receiving D-incompatible single-donor platelets. Transfusion 2002; 42: 177-82
64. Radwan ZA, Bai Y, Matijevic N, et al. An emergency department thawed plasma protocol for severely injured patients. JAMA Surg 2013; 148: 170-5
65. Mehr CR, Gupta R, von Recklinghausen FM, Szczepiorkowski ZM, Dunbar NM. Balancing risk and benefit: maintenance of a thawed group A plasma inventory for trauma patients requiring massive transfusion. J Trauma Acute Care Surg 2013; 74: 1425-31
66. GoodnoughLT, SpainDA,MaggioP. Logistics of transfusion support for patients with massive hemorrhage. Curr Opin Anaesthesiol 2013; 26: 208-14
67. Boffard KD, Riou B,Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, doubleblind clinical trials. J Trauma 2005; 59: 8-15; discussion 15-8
68. Hauser CJ, Boffard K, Dutton R, et al. Results of the CONTROL trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010; 69: 489-500
69. Fries D. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. Transfusion 2013; 53(Suppl. 1): 91-5S.
70. Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010; 363: 1791-800
71. Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis. Can Med Assoc J 2011; 183: E9-19
72. Callum JL, Rizoli S. Assessment and management of massive bleeding: coagulation assessment, pharmacologic strategies, and transfusion management. Hematology Am Soc Hematol Educ Program 2012; 2012: 522-8
73. Perkins JG, Schreiber MA,Wade CE, Holcomb JB. Early versus late recombinant factor VIIaincombat trauma patients requiringmassive transfusion. J Trauma 2007; 62: 1095-9; discussion 9-101
74. Mitterlechner T, Innerhofer P, Streif W, et al. Prothrombin complex concentrate and recombinant prothrombin alone or in combination with recombinant factor X and FVIIa in dilutional coagulopathy: a porcine model. J Thromb Haemost 2011; 9: 729-37
75. GrottkeO,Braunschweig T, SpronkHM, et al. Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood 2011; 118: 1943-51
76. Fenger-Eriksen C, Jensen TM, Kristensen BS, et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009; 7: 795-802
77. KarlssonM, TernstromL, HyllnerM, et al. Prophylactic fibrinogeninfusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 2009; 102: 137-44
78. Rahe-Meyer N, Pichlmaier M, Haverich A, et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 2009; 102: 785-92
79. Rahe-Meyer N, Solomon C, Winterhalter M, et al. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominalaorticaneurysmsurgery. J ThoracCardiovasc Surg 2009; 138: 694-702
80. Schochl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55
81. Innerhofer P, Westermann I, Tauber H, et al. The exclusive use of coagulation factorconcentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013; 44: 209-16
82. Tanaka KA, Esper S, Bolliger D. Perioperative factor concentrate therapy. Br J Anaesth 2013; 111(Suppl. 1): i35-i49
83. Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23-32
84. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) study. Arch Surg 2012; 147: 113-9
85. Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096-101, 1101.e1-2
86. Guerriero C, Cairns J, Perel P, Shakur H, Roberts I. Costeffectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One 2011; 6: e18987
87. Roberts I, Ker K. Tranexamic acid for postpartum bleeding. Int J Gynaecol Obstet 2011; 115: 220-1
88. Ducloy-Bouthors AS, Jude B, Duhamel A, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 2011; 15: R117
89. Pasquali SK, Li JS, He X, et al. Comparative analysis of antifibrinolytic medications in pediatric heart surgery. J ThoracCardiovasc Surg 2012; 143: 550-7
90. Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 2005; 102: 727-32
91. Tripodi A, Chantarangkul V, Mannucci PM. Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing. Br J Haematol 2009; 147: 77-82
92. MannKG,ButenasS,BrummelK.Thedynamicsof thrombinformation. Arterioscler Thromb Vasc Biol 2003; 23: 17-25
93. Dzik WH. Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 2004; 3: 324-30
94. Davenport R, Khan S. Management of major trauma haemorrhage: treatment priorities and controversies. Br J Haematol 2011; 155: 537-48
95. Bolliger D, Seeberger MD, Tanaka KA. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 2012; 26: 1-13
96. Kettner SC, Kozek SA, Groetzner JP, et al. Effects of hypothermia on thrombelastography in patients undergoing cardiopulmonary bypass. Br J Anaesth 1998; 80: 313-7
97. Girdauskas E, Kempfert J, Kuntze T, et al. Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial. J Thorac Cardiovasc Surg 2010; 140: 1117-24.e2
98. Ak K, Isbir CS, Tetik S, et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg 2009; 24: 404-10
99. Wikkelsoe AJ, Afshari A,Wetterslev J, Brok J, Moeller AM. Monitoringpatientsat riskofmassivetransfusionwiththrombelastography or thromboelastometry: a systematic review. Acta Anaesthesiol Scand 2011; 55: 1174-89
100. Coakley M, Reddy K, Mackie I, Mallett S. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth 2006; 20: 548-53
101. Afshari A, Wikkelso A, Brok J, Moller AM,Wetterslev J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011; CD007871.
102. Wang D, Sun J, Solomon SB, Klein HG, Natanson C. Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion 2012; 52: 1184-95
103. Fergusson DA, Hebert P, Hogan DL, et al. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. J Am Med Assoc 2012; 308: 1443-51
104. Cohen B, Matot I. Aged erythrocytes-a fine wine or sour grapes? Br J Anaesth 2013; 111(Suppl. 1): i62-i70